AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
152 hedge funds and large institutions have $1.7B invested in Amedisys in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 21
4% less funds holding
Funds holding: 159 → 152 (-7)
35% less call options, than puts
Call options by funds: $2.03M | Put options by funds: $3.11M
Holders
152
Holding in Top 10
1
Calls
$2.03M
Puts
$3.11M
Top Buyers
| 1 | +$280M | |
| 2 | +$36.7M | |
| 3 | +$22.2M | |
| 4 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
+$8.98M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$8.63M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$13.8M | |
| 3 | -$12.2M | |
| 4 |
Renaissance Technologies
New York
|
-$12.1M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$8.98M |